KR890012541A - 안정화된 마크롤리드 조성물 - Google Patents
안정화된 마크롤리드 조성물 Download PDFInfo
- Publication number
- KR890012541A KR890012541A KR1019890001931A KR890001931A KR890012541A KR 890012541 A KR890012541 A KR 890012541A KR 1019890001931 A KR1019890001931 A KR 1019890001931A KR 890001931 A KR890001931 A KR 890001931A KR 890012541 A KR890012541 A KR 890012541A
- Authority
- KR
- South Korea
- Prior art keywords
- compound
- formula
- composition
- antioxidant
- derivative
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Agronomy & Crop Science (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Communicable Diseases (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Saccharide Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicinal Preparation (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Pyrane Compounds (AREA)
- Macromonomer-Based Addition Polymer (AREA)
- Cosmetics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Steroid Compounds (AREA)
Abstract
내용 없음.
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (10)
- 하기 구조식(I)의 화합물 또는 그의 유도체와 항산화제로 구성되는 안정화된 조성물.상기 식중, R1은 메틸, 에틸 또는 이소프로필기이고, R2는 수소 원자 또는 메틸기이다.
- 제1항에 있어서, 구조식(I)의 화합물 중 R1이 이소프로필기이고, R2가 수소 원자인 것을 특징으로 하는 조성물.
- 제1항에 있어서, 황산화제가 C1-12알킬 몰식자산염, 벤질 히드록시벤조에이트 또는 C1-16알킬 히드록시 벤조에이트 또는 그의 염, 부틸화 히드록시아니솔, 부틸화 히드록시톨루엔, 퀴논 또는 그의 염, 노르디히드로과이어레트산, 또는 α-코토페롤인 것을 특징으로 하는 조성물.
- 제1항에 있어서, 항산화제가 부틸화 히드록시톨루엔인 것을 특징으로 하는 조성물.
- 제1항에 있어서, 항상화제를 구조식(I)의 화합물 또는 그의 유도체의 0.005 내지 1중량%로 함유하는 것을 특징으로 하는 조성물.
- 제1항에 있어서, 살충제로서 사용하기에 적당한 형태이며, 1종 이상의 담체 또는 부형제를 함유하는 것을 특징으로 하는 조성물.
- 구조식(I)의 화합물 또는 그의 유도체와 항산화제를 혼합하는 것으로 되는 제1항에 의한 조성물의 제조 방법.
- 제7항에 있어서, 상기 화합물 및 항산화제가 용액으로부터 공침전되는 것을 특징으로 하는 방법.
- 제1항에 의한 조성물을 해충 또는 그 소재지에 투여하는 것으로 되는 곤충, 진드기 또는 선충류 해충의 방제법.
- 구조식(I)의 화합물 또는 그의 유도체를 항상화제와 접촉시키는 것으로 되는 상기 화합물의 안정화 방법.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8803836 | 1988-02-18 | ||
GB888803836A GB8803836D0 (en) | 1988-02-18 | 1988-02-18 | Compositions |
GB8803836 | 1988-02-18 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR890012541A true KR890012541A (ko) | 1989-09-18 |
KR960011234B1 KR960011234B1 (ko) | 1996-08-21 |
Family
ID=10631977
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019890001931A KR960011234B1 (ko) | 1988-02-18 | 1989-02-18 | 안정화된 마크롤리드 조성물 |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP0329460B1 (ko) |
JP (1) | JP2843591B2 (ko) |
KR (1) | KR960011234B1 (ko) |
AT (1) | ATE76291T1 (ko) |
AU (1) | AU625746B2 (ko) |
BR (1) | BR8900688A (ko) |
CA (1) | CA1323835C (ko) |
DD (1) | DD297821A5 (ko) |
DE (1) | DE68901543D1 (ko) |
DK (1) | DK175300B1 (ko) |
ES (1) | ES2031351T3 (ko) |
GB (1) | GB8803836D0 (ko) |
GR (1) | GR3004648T3 (ko) |
HU (1) | HU203189B (ko) |
IE (1) | IE61053B1 (ko) |
NZ (1) | NZ228038A (ko) |
PT (1) | PT89760B (ko) |
ZA (1) | ZA891248B (ko) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0432494B1 (en) * | 1989-12-15 | 1997-02-05 | American Cyanamid Company | Pour-on formulations effective for the control of internal and external parasites of homothermic animals |
US6514951B1 (en) | 1989-12-15 | 2003-02-04 | American Cyanamid Company | Pour-on formulations effective for the control of internal and external parasites of homothermic animals |
US5346698A (en) * | 1991-01-15 | 1994-09-13 | Mycogen Corporation | Synergistic pesticidal compositions |
JP2540394B2 (ja) * | 1991-05-28 | 1996-10-02 | ニチアス株式会社 | エルボカバ―の製造方法および製造装置 |
ES2086022T3 (es) * | 1991-07-23 | 1996-06-16 | American Cyanamid Co | Composiciones estables para administracion parenteral y su uso. |
RO115102B1 (ro) * | 1993-05-10 | 1999-11-30 | Merck & Co Inc | Formulari topice pe baza de avermectina si procedee de preparare a acestora |
US5602107A (en) * | 1993-05-10 | 1997-02-11 | Merck & Co., Inc. | Pour-on formulations consisting of gylcols, glycerides and avermectin compounds |
PL174488B1 (pl) * | 1993-05-10 | 1998-08-31 | Merck & Co Inc | Preparat do zwalczania pasożytów zwierząt oraz sposób wytwarzania preparatu do zwalczania pasożytów zwierząt |
GB9826882D0 (en) | 1998-12-07 | 1999-01-27 | Novartis Ag | Organic compounds |
DK1197215T3 (da) * | 2000-10-10 | 2006-07-10 | Wyeth Corp | Anthelmintiske sammensætninger |
BG64140B1 (bg) * | 2000-12-21 | 2004-02-27 | "Биовет" Ад | Състав за растителна защита с инсектицидно и акарицидно действие |
ATE385795T1 (de) | 2002-07-30 | 2008-03-15 | Wyeth Corp | Parenterale formulierungen mit einem rapamycin hydroxyester |
US20080125480A1 (en) * | 2004-12-30 | 2008-05-29 | Cheminova A/S | Oil-In-Water Formulation Of Avermectins |
EP1962819A1 (en) * | 2005-12-20 | 2008-09-03 | Wyeth | Control of cci-779 dosage form stability through control of drug substance impurities |
FR2906467B1 (fr) * | 2006-09-28 | 2012-11-09 | Galderma Sa | Utilisation de composes de la famille des milbemycines pour le traitement de desordres dermatologiques chez l'homme |
JP2024523472A (ja) | 2021-06-25 | 2024-06-28 | インターベット インターナショナル ベー. フェー. | 口当たりの良い動物用組成物 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH408284A (de) * | 1958-06-26 | 1966-02-28 | Philips Nv | Verfahren zum Stabilisieren kristallinischer Verbindungen gegen Oxydation |
NZ197796A (en) * | 1980-08-04 | 1984-11-09 | Merck & Co Inc | Stabilised aqueous formulations containing ivermectin |
JPS5920285A (ja) * | 1982-07-23 | 1984-02-01 | Sankyo Co Ltd | ミルベマイシンdの5−二塩基酸エステル誘導体及びその塩 |
AU2314184A (en) * | 1983-01-10 | 1984-07-12 | Robert Young & Company Limited | Endoparasiticidal composition containing levamisole |
NZ210505A (en) * | 1983-12-22 | 1988-06-30 | Merck & Co Inc | Parasiticidal compositions containing avermectin or milbemycin derivatives |
GB2166436B (en) * | 1984-09-14 | 1989-05-24 | Glaxo Group Ltd | Antibiotic compounds and their preparation |
-
1988
- 1988-02-18 GB GB888803836A patent/GB8803836D0/en active Pending
-
1989
- 1989-02-17 AT AT89301547T patent/ATE76291T1/de not_active IP Right Cessation
- 1989-02-17 EP EP89301547A patent/EP0329460B1/en not_active Expired - Lifetime
- 1989-02-17 HU HU89803A patent/HU203189B/hu unknown
- 1989-02-17 JP JP1036430A patent/JP2843591B2/ja not_active Expired - Lifetime
- 1989-02-17 BR BR898900688A patent/BR8900688A/pt not_active IP Right Cessation
- 1989-02-17 DE DE8989301547T patent/DE68901543D1/de not_active Expired - Lifetime
- 1989-02-17 ES ES198989301547T patent/ES2031351T3/es not_active Expired - Lifetime
- 1989-02-17 DD DD89325851A patent/DD297821A5/de unknown
- 1989-02-17 DK DK198900756A patent/DK175300B1/da not_active IP Right Cessation
- 1989-02-17 IE IE51089A patent/IE61053B1/en not_active IP Right Cessation
- 1989-02-17 NZ NZ228038A patent/NZ228038A/en unknown
- 1989-02-17 PT PT89760A patent/PT89760B/pt not_active IP Right Cessation
- 1989-02-17 ZA ZA891248A patent/ZA891248B/xx unknown
- 1989-02-17 AU AU30065/89A patent/AU625746B2/en not_active Expired
- 1989-02-17 CA CA000591355A patent/CA1323835C/en not_active Expired - Lifetime
- 1989-02-18 KR KR1019890001931A patent/KR960011234B1/ko not_active IP Right Cessation
-
1992
- 1992-05-21 GR GR910401864T patent/GR3004648T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
NZ228038A (en) | 1991-07-26 |
CA1323835C (en) | 1993-11-02 |
ZA891248B (en) | 1989-10-25 |
ATE76291T1 (de) | 1992-06-15 |
GR3004648T3 (ko) | 1993-04-28 |
JP2843591B2 (ja) | 1999-01-06 |
HU203189B (en) | 1991-06-28 |
IE890510L (en) | 1989-08-18 |
JPH023690A (ja) | 1990-01-09 |
EP0329460A3 (en) | 1989-10-18 |
AU3006589A (en) | 1989-08-24 |
KR960011234B1 (ko) | 1996-08-21 |
IE61053B1 (en) | 1994-09-21 |
HUT50629A (en) | 1990-03-28 |
PT89760B (pt) | 1994-03-31 |
DK175300B1 (da) | 2004-08-16 |
PT89760A (pt) | 1989-10-04 |
DE68901543D1 (de) | 1992-06-25 |
DD297821A5 (de) | 1992-01-23 |
ES2031351T3 (es) | 1992-12-01 |
EP0329460B1 (en) | 1992-05-20 |
AU625746B2 (en) | 1992-07-16 |
DK75689D0 (da) | 1989-02-17 |
BR8900688A (pt) | 1989-10-10 |
GB8803836D0 (en) | 1988-03-16 |
EP0329460A2 (en) | 1989-08-23 |
DK75689A (da) | 1989-08-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR890012541A (ko) | 안정화된 마크롤리드 조성물 | |
SE8601998L (sv) | Kemiska foreningar | |
KR890002043A (ko) | 치환된 벤조일페닐 우레아 | |
KR940014359A (ko) | 살충제 및 진드기 구충제로서 n-아릴히드라진 유도체 | |
HUT49986A (en) | Composition comprising alpha, omega-aminoalcohol derivative as active ingredient, for expelling insects and mites and process for producing new alpha, omega-aminoalcohol derivatives | |
KR880000441A (ko) | 마크롤라이드 화합물 | |
KR890009845A (ko) | 아릴옥시페닐 프로필아민, 이의 제조방법 및 용도 | |
KR910009148A (ko) | 페이스트형 살충제 조성물 | |
JPS5538390A (en) | Aroylurea*its manufacture and insecticide and miticide containing it | |
KR930021609A (ko) | 페닐아세트산 유도체, 그의 제조 방법 및 농약으로서의 그의 용도 | |
NZ219576A (en) | Milbemycin derivatives and pharmaceutical, veterinary, and pesticidal compositions | |
KR870011093A (ko) | N-시아노알킬이소니코틴아미드 유도체 | |
KR890011889A (ko) | 마크롤라이드 화합물 | |
US3839586A (en) | Mosquito control employing certain 2,6-disubstituted phenols | |
KR850005227A (ko) | 농원예용 살균제 조성물 | |
KR890005119A (ko) | 마크롤리드 화합물 | |
AR245567A1 (es) | Composicion para atraer cucarachas. | |
KR830001900A (ko) | 페닐모르판과 그의 중간물질및 제조방법 | |
KR920012069A (ko) | 이미다졸리딘 유도체, 이의 제조방법, 유효 성분으로서 이것을 함유하는 살충제 및 그에 의한 중간체 | |
KR840005801A (ko) | 균질성 액상 조성물 | |
ES8708215A1 (es) | Procedimiento para la obtencion de 1,2,4-triazoles | |
KR870001153A (ko) | 디페녹시에틸아민 유도체가 함유된 약제조성물 및 그의 생산방법 | |
JPS5756405A (en) | Stabilizing method | |
KR910019965A (ko) | 오르토-치환된 시클로프로판카르복실산의 벤질 에스테르 | |
KR880013874A (ko) | 카르복실산 에스테르, 그의 제조방법 및 그것을 유효 성분으로 함유하는 살충제 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
G160 | Decision to publish patent application | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20100729 Year of fee payment: 15 |
|
EXPY | Expiration of term |